Pfizer and BioNTech Submit COVID-19 Vaccine for Emergency Use Approval in U.S.
Pfizer Inc. and BioNTech SE announced they will submit a request today to the U.S. Food and Drug Administration (FDA) for Emergency Use ...
Pfizer Inc. and BioNTech SE announced they will submit a request today to the U.S. Food and Drug Administration (FDA) for Emergency Use ...
Last month, the Food and Drug Administration (FDA) gave its first full approval for a COVID-19 therapeutic to Gilead Sciences' ...
With multiple promising SARS-CoV-2 vaccine candidates now under development, the National Institute of Allergy and Infectious Diseases (NIAID) is looking ...
When it comes to how the coronavirus invades a cell, it takes three to tango. The dance began with the ...
Lawrence Livermore National Laboratory (LLNL), along with partners Intel, Supermicro and Cornelis Networks, have deployed “Ruby,” a high performance computing (HPC) ...
Based on the recommendation of the independent data monitoring committee (IDMC), Regeneron Pharmaceuticals has stopped enrolling patients receiving advanced COVID-19 care ...
The drug tocilizumab (Actemra) does not reduce the need for breathing assistance with mechanical ventilation or prevent death in moderately ...
U of M trial shows hydroxychloroquine does not prevent COVID-19 in health care workers University of Minnesota Medical School physician ...
Researchers led by the University of California, San Francisco and the University of Alberta, Edmonton have engineered angiotensin-converting enzyme II ...
Military units conduct reconnaissance missions to obtain information – by visual observation or other detection methods – about the activities ...
Centivax Inc, the therapeutics spinout of Contract Research Organization Distributed Bio Inc, announced today a licensing agreement with Thermo Fisher ...
In recovering COVID-19 patients, antibodies fade quickly, but adequate time must be given to clear viral particles before plasma collection ...
The yearly influenza season threatens to make the COVID-19 pandemic doubly deadly, but I believe that this isn’t inevitable. There ...
A large international consortium of almost 200 researchers from 14 leading institutions in six countries has studied three different coronaviruses ...
The U.S. Department of Health and Human Services and Department of Defense this week announced an agreement with Cytiva to ...
Virologists at the Rega Institute have shown that the anti-malaria drug hydroxychloroquine does not limit SARS-CoV-2 coronavirus replication in hamsters. ...
In a new study, researchers from the Dangerous Pathogens Team at CSIRO conclude vaccines currently under development for COVID-19 should ...
Eli Lilly and Company today announced additional details on its SARS-CoV-2 neutralizing antibody programs – including interim data on combination therapy ...
To bring COVID-19 under control a vaccine needs to be available to every nation, rich and poor – and it ...
Just like a fresh piece of fish, vaccines are highly perishable products and must be kept at very cold, specific ...